Effect of HPSE and HPSE2 SNPs on the Risk of Developing Primary Paraskeletal Multiple Myeloma

Multiple myeloma (MM) is a plasma cell malignancy that is accompanied by hypercalcemia, renal failure, anemia, and lytic bone lesions. Heparanase (HPSE) plays an important role in supporting and promoting myeloma progression, maintenance of plasma cell stemness, and resistance to therapy. Previous s...

Full description

Bibliographic Details
Main Authors: Olga Ostrovsky, Katia Beider, Hila Magen, Merav Leiba, Ralph D. Sanderson, Israel Vlodavsky, Arnon Nagler
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/12/6/913
_version_ 1797612851223855104
author Olga Ostrovsky
Katia Beider
Hila Magen
Merav Leiba
Ralph D. Sanderson
Israel Vlodavsky
Arnon Nagler
author_facet Olga Ostrovsky
Katia Beider
Hila Magen
Merav Leiba
Ralph D. Sanderson
Israel Vlodavsky
Arnon Nagler
author_sort Olga Ostrovsky
collection DOAJ
description Multiple myeloma (MM) is a plasma cell malignancy that is accompanied by hypercalcemia, renal failure, anemia, and lytic bone lesions. Heparanase (HPSE) plays an important role in supporting and promoting myeloma progression, maintenance of plasma cell stemness, and resistance to therapy. Previous studies identified functional single nucleotide polymorphisms (SNPs) located in the HPSE gene. In the present study, 5 functional HPSE SNPs and 11 novel HPSE2 SNPs were examined. A very significant association between two enhancer (rs4693608 and rs4693084), and two insulator (rs4364254 and rs4426765) HPSE SNPs and primary paraskeletal disease (PS) was observed. SNP rs657442, located in intron 9 of the HPSE2 gene, revealed a significant protective association with primary paraskeletal disease and lytic bone lesions. The present study demonstrates a promoting (HPSE gene) and protective (HPSE2 gene) role of gene regulatory elements in the development of paraskeletal disease and bone morbidity. The effect of signal discrepancy between myeloma cells and normal cells of the tumor microenvironment is proposed as a mechanism for the involvement of heparanase in primary PS. We suggest that an increase in heparanase-2 expression can lead to effective suppression of heparanase activity in multiple myeloma accompanied by extramedullary and osteolytic bone disease.
first_indexed 2024-03-11T06:47:48Z
format Article
id doaj.art-96093207e230487dbe545e4390f6fa9f
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-11T06:47:48Z
publishDate 2023-03-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-96093207e230487dbe545e4390f6fa9f2023-11-17T10:13:38ZengMDPI AGCells2073-44092023-03-0112691310.3390/cells12060913Effect of HPSE and HPSE2 SNPs on the Risk of Developing Primary Paraskeletal Multiple MyelomaOlga Ostrovsky0Katia Beider1Hila Magen2Merav Leiba3Ralph D. Sanderson4Israel Vlodavsky5Arnon Nagler6Department of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer 5266202, IsraelDepartment of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer 5266202, IsraelDepartment of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer 5266202, IsraelDepartment of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer 5266202, IsraelDepartment of Pathology, University of Alabama at Birmingham, Birmingham, AL 35294, USATechnion Integrated Cancer Center (TICC), Rappaport Faculty of Medicine, Technion, Haifa 3525433, IsraelDepartment of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer 5266202, IsraelMultiple myeloma (MM) is a plasma cell malignancy that is accompanied by hypercalcemia, renal failure, anemia, and lytic bone lesions. Heparanase (HPSE) plays an important role in supporting and promoting myeloma progression, maintenance of plasma cell stemness, and resistance to therapy. Previous studies identified functional single nucleotide polymorphisms (SNPs) located in the HPSE gene. In the present study, 5 functional HPSE SNPs and 11 novel HPSE2 SNPs were examined. A very significant association between two enhancer (rs4693608 and rs4693084), and two insulator (rs4364254 and rs4426765) HPSE SNPs and primary paraskeletal disease (PS) was observed. SNP rs657442, located in intron 9 of the HPSE2 gene, revealed a significant protective association with primary paraskeletal disease and lytic bone lesions. The present study demonstrates a promoting (HPSE gene) and protective (HPSE2 gene) role of gene regulatory elements in the development of paraskeletal disease and bone morbidity. The effect of signal discrepancy between myeloma cells and normal cells of the tumor microenvironment is proposed as a mechanism for the involvement of heparanase in primary PS. We suggest that an increase in heparanase-2 expression can lead to effective suppression of heparanase activity in multiple myeloma accompanied by extramedullary and osteolytic bone disease.https://www.mdpi.com/2073-4409/12/6/913HPSE geneHPSE2 geneSNPsmultiple myelomaextramedullary disease
spellingShingle Olga Ostrovsky
Katia Beider
Hila Magen
Merav Leiba
Ralph D. Sanderson
Israel Vlodavsky
Arnon Nagler
Effect of HPSE and HPSE2 SNPs on the Risk of Developing Primary Paraskeletal Multiple Myeloma
Cells
HPSE gene
HPSE2 gene
SNPs
multiple myeloma
extramedullary disease
title Effect of HPSE and HPSE2 SNPs on the Risk of Developing Primary Paraskeletal Multiple Myeloma
title_full Effect of HPSE and HPSE2 SNPs on the Risk of Developing Primary Paraskeletal Multiple Myeloma
title_fullStr Effect of HPSE and HPSE2 SNPs on the Risk of Developing Primary Paraskeletal Multiple Myeloma
title_full_unstemmed Effect of HPSE and HPSE2 SNPs on the Risk of Developing Primary Paraskeletal Multiple Myeloma
title_short Effect of HPSE and HPSE2 SNPs on the Risk of Developing Primary Paraskeletal Multiple Myeloma
title_sort effect of hpse and hpse2 snps on the risk of developing primary paraskeletal multiple myeloma
topic HPSE gene
HPSE2 gene
SNPs
multiple myeloma
extramedullary disease
url https://www.mdpi.com/2073-4409/12/6/913
work_keys_str_mv AT olgaostrovsky effectofhpseandhpse2snpsontheriskofdevelopingprimaryparaskeletalmultiplemyeloma
AT katiabeider effectofhpseandhpse2snpsontheriskofdevelopingprimaryparaskeletalmultiplemyeloma
AT hilamagen effectofhpseandhpse2snpsontheriskofdevelopingprimaryparaskeletalmultiplemyeloma
AT meravleiba effectofhpseandhpse2snpsontheriskofdevelopingprimaryparaskeletalmultiplemyeloma
AT ralphdsanderson effectofhpseandhpse2snpsontheriskofdevelopingprimaryparaskeletalmultiplemyeloma
AT israelvlodavsky effectofhpseandhpse2snpsontheriskofdevelopingprimaryparaskeletalmultiplemyeloma
AT arnonnagler effectofhpseandhpse2snpsontheriskofdevelopingprimaryparaskeletalmultiplemyeloma